234. COVID-19: Vaccines: Saturday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Vaccines
Paul LOUBET, MD, PhD (he/him/his)
Infectious Diseases Specialist
CHU de Nîmes
Nimes, Languedoc-Roussillon, France
Camille Gilbert, PhD
Université de Bordeaux, INSERM UMS 54 MART, ISPED, Bordeaux, France
Bordeaux, Aquitaine, France
David Laplaud, MD, PhD
CHU de Nantes
Nantes, Pays de la Loire, France
Martine Laville, n/a
CHU Lyon
Lyon, Rhone-Alpes, France
Bruno Laviolle, n/a
CHU Rennes
Rennes, Bretagne, France
Jean-Daniel Lelièvre, n/a
CHU Henri Mondor
Creteil, Ile-de-France, France
Jean-Yves Blay, n/a
Unicancer Lyon
Lyon, Rhone-Alpes, France
Benoit Barrou, n/a
APHP
Paris, Ile-de-France, France
Benjamin Terrier, n/a
APHP
Paris, Ile-de-France, France
Stéphanie Nguyen Quoc, MD, PhD
Hopital Pitié-Salpétrière
Paris, Ile-de-France, France
Aude Barquin, MD
Université de Bordeaux, INSERM UMS 54 MART, ISPED, Bordeaux, France
Bordeaux, Aquitaine, France
Cécile Moins, n/a
ANRS
Paris, Ile-de-France, France
Eric Tartour, MD, PHD
Service d’Immunologie Biologique, APHP, Hôpital Européen Georges Pompidou, 75015 Paris, France ; PARCC, INSERM U970, Université de Paris, 75006 Paris, France
Paris, Ile-de-France, France
Xavier de Lamballerie, n/a
Prof
APHM
Marseille, Provence-Alpes-Cote d'Azur, France
Odile Launay, MD, PhD
Head of I Reivac, French vaccine research network
Université Paris Cité; Inserm F-CRIN, I-REIVAC; Assistance Publique Hôpitaux de Paris
Paris, Ile-de-France, France
LInda Wittkop, n/a
Université Bordeaux
Bordeaux, Aquitaine, France